Clinical Trial Update: Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury [Phase 2]

View source ↗

Summary

Phase 2 trial update on using allogeneic UCMSCs to treat knee osteoarthritis shows completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• UCMSCs (umbilical cord mesenchymal stem cells) from allogeneic source (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Cytopeutics Sdn. Bhd. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED